Literature DB >> 10841997

Serologic survey of Neospora caninum infection in a closed dairy cattle herd in Maryland: risk of serologic reactivity by production groups.

R M Dyer1, M C Jenkins, O C Kwok, L W Douglas, J P Dubey.   

Abstract

Prevalence of antibodies to Neospora caninum was determined in a cross-sectional consensus survey of 1029 bovines in a dairy herd with endemic Neospora-induced abortion. Sera were screened by indirect fluorescent antibody test (IFAT). The prevalence of N. caninum antibody in the IFAT was 17.9% in 107 neonates, 26.2% in 233 yearling heifers and steers, 39.07% in 218 mature heifers, and 26.9% in 465 milking cows. Serologic reactivity was associated with production grouping on the farm with the greatest risk of serologic reactivity appearing in the yearling and mature heifers. There was an increasing risk of serologic reactivity with increasing age only in the parity one and greater animals in the herd. Castrated males were at half the risk of similarly aged females of possessing antibodies to N. caninum. There was no clear relationship between the serologic status of dams and offspring.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841997     DOI: 10.1016/s0304-4017(00)00253-3

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Prevalence of Neospora caninum antibodies in dairy cattle and water buffaloes and associated abortions in the plateau of Southern Peninsular India.

Authors:  P P Sengupta; M Balumahendiran; A G Raghavendra; T G Honnappa; M R Gajendragad; K Prabhudas
Journal:  Trop Anim Health Prod       Date:  2012-05-30       Impact factor: 1.559

2.  Prevalence and risk factors associated with Neospora caninum infection in dairy herds in Jordan.

Authors:  Abdelsalam Q Talafha; Ahmad M Al-Majali
Journal:  Trop Anim Health Prod       Date:  2012-08-07       Impact factor: 1.559

Review 3.  Epidemiology and control of neosporosis and Neospora caninum.

Authors:  J P Dubey; G Schares; L M Ortega-Mora
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.